Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Meeting Point Health — Peptide Therapy in Philadelphia, PA

Meeting Point Health Nearby Clinics Philadelphia, PA Peptides & Treatments About Meeting Point Health operates as a comprehensive regenerative medicine practice in Philadelphia, PA, combining board-certified expertise in primary care, non-surgical orthopedics,

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Meeting Point Health

Nearby Clinics

Philadelphia, PA

Peptides & Treatments

About

Meeting Point Health operates as a comprehensive regenerative medicine practice in Philadelphia, PA, combining board-certified expertise in primary care, non-surgical orthopedics, and stem cell therapy under one clinical roof. The practice addresses both acute orthopedic injuries and chronic degenerative conditions through evidence-based regenerative protocols, with particular emphasis on patients seeking alternatives to surgical intervention or long-term pharmaceutical management. With 165 patient reviews averaging 4.8 stars, the clinic has established a reputation in the Philadelphia area for thorough diagnostic evaluation and multimodal treatment planning that integrates peptide therapy, platelet-rich plasma procedures, and functional medicine principles.

The peptide therapy program at Meeting Point Health centers on three distinct compounds selected for their research-supported applications in neurological function and tissue repair. Semax, a synthetic peptide derived from adrenocorticotropic hormone, is utilized for cognitive enhancement and neuroprotection in patients experiencing brain fog, post-concussion syndrome, or age-related cognitive decline. Selank, an anxiolytic peptide with immune-modulating properties, is prescribed for patients managing chronic stress, anxiety disorders, or inflammatory conditions where the stress-immune axis plays a central role. Copper peptides, specifically GHK-Cu formulations, are incorporated into both topical and injectable protocols for wound healing, collagen synthesis, and skin rejuvenation in anti-aging treatment plans. These peptides are prescribed following comprehensive laboratory assessment and are monitored through follow-up visits at the Philadelphia clinic location.

The clinical team's board certifications in non-surgical orthopedics and stem cell therapy directly inform the practice's approach to musculoskeletal conditions, particularly lower back pain, sports-related injuries, and degenerative joint disease. Patients presenting with orthopedic pain undergo diagnostic evaluation that may include musculoskeletal ultrasound, functional movement assessment, and laboratory testing to identify underlying inflammatory or metabolic contributors. Treatment protocols frequently combine peptide therapy with platelet-rich plasma injections, acupuncture, and targeted rehabilitation exercises. The practice also addresses complex chronic conditions including Lyme disease, where functional medicine testing is used to assess immune function, mitochondrial health, and systemic inflammation before designing individualized treatment protocols that may incorporate peptide therapy alongside antimicrobial and immune support strategies.

Patients at Meeting Point Health can expect in-person consultations at the Philadelphia office, where initial visits typically involve comprehensive health history review, physical examination, and discussion of treatment goals. The practice does not offer telehealth services, requiring all peptide therapy patients to be seen in person for prescription, administration training, and ongoing monitoring. Follow-up schedules are determined based on the specific peptides prescribed and the condition being treated, with most patients returning every 4-8 weeks during active treatment phases. The clinic's approach emphasizes patient education regarding peptide administration techniques, expected timelines for clinical response, and integration of peptides within broader lifestyle and nutritional interventions. For orthopedic patients, treatment plans often include coordination with physical therapists and exercise specialists to optimize functional outcomes.

What distinguishes Meeting Point Health in the Philadelphia regenerative medicine landscape is the integration of board-certified orthopedic expertise with functional medicine diagnostics and peptide therapeutics. Rather than offering peptides as standalone treatments, the practice embeds them within comprehensive care plans that address root causes of dysfunction, whether metabolic, inflammatory, or biomechanical. The clinic's experience with both acute sports injuries and chronic complex conditions like Lyme disease allows for nuanced treatment design that considers immune status, tissue healing capacity, and neurological function. Patients seeking alternatives to corticosteroid injections for joint pain or those interested in longevity medicine protocols that extend beyond basic hormone replacement will find the clinic's multimodal approach particularly relevant. The practice accepts in-person consultations for new patients and maintains an active caseload of individuals managing conditions ranging from athletic performance optimization to age-related functional decline.

Care Team

Our Team

Dr. Stephen Matta, DO MBA CAQSM

Physician

Dr. Matta is a triple board-certified physician in Primary Care, Non-Surgical Orthopedics, and Stem Cell Therapy. He is a master diagnostician who specializes in anti-aging, orthopedic pain, and functional medicine, using cutting-edge holistic therapies such as ultrasound-guided regenerative injections, osteopathic manipulation, acupuncture, IV nutrient therapy, and ozone therapy.

Mary Anne Matta, MS, MA, LAC

Licensed Acupuncturist

Mary Anne approaches each of her treatment protocols with a highly educated, evidence-informed approach. She will observe your presenting symptoms, in addition to what makes your body unique: body structure, chronic infection and toxicity, and environmental factors.

Topics Mentioned in Reviews

Patient Reviews

FAQ

MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01What if I travel frequently? Can I continue peptide therapy?

Most injectable peptides travel reasonably well with proper handling. Your clinic should provide guidance on traveling with peptides, including storage requirements and TSA considerations. Understanding peptide stability at room temperature helps plan for travel situations.

Source: seekpeptides.com ↗
comparison

Keto supplements versus GLP-1 medications: they are not the same thing

This distinction requires absolute clarity because confusion here can be dangerous. Exogenous ketone supplements, MCT oil products, and "keto pills" sold over the counter are NOT GLP-1 rece…

Source: seekpeptides.com
comparison

Inflammation reduction versus fat reduction: which matters more?

This is the question that the Italian exenatide study highlighted so powerfully. Case 1 lost no weight but still experienced pain reduction and measurable changes in subcutaneous fat thickn…

Source: seekpeptides.com
Research context

Read sources and limitations before applying a claim.

Human Evidence Key

Extensive Multiple randomized controlled trials and/or established clinical use Moderate Multiple human studies with encouraging evidence, but not standard therapy Limited Small clinical studies or early-phase trials Very Limited / Minimal Predominantly animal, laboratory, or mechanistic research with little human evidence

Source: r2medicalclinic.com ↗

Hope or Hype? Evaluating the Evidence

The excitement around peptide therapy reflects a desire for safer, more targeted treatments. Early studies suggest peptides can modulate immune responses, promote tissue repair, and improve gut integrity. However, most evidence comes from animal models or small human trials. There is a lack of large randomized clinical studies evaluating the effectiveness in autoimmune diseases. Without robust data, it is hard to distinguish hope from hype. Peptides are not magic bullets. They may provide incremental benefits when used appropriately and under supervision. Overblown claims and self‑administration can lead to disappointment or harm. When evaluating peptides, consider the quality of evidence, personal health history, and your healthcare provider’s guidance. Ask whether there are published studies, what outcomes were measured, and whether results apply to your condition. Remain cautious of marketing that promises cures or uses pseudoscience. Balanced optimism will help you navigate the emerging field of peptide therapy.

Source: livvnatural.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

How-to reference

How to Cite This Report

MyPeptideMatch.com. (2026, March 5). State of Peptide Therapy in the US — 2026 Data Report. Retrieved from https://www.mypeptidematch.com/research/peptide-therapy-report-2026 This report is freely available for citation under CC BY 4.0. When citing, please link to this URL. For media inquiries, contact us at mypeptidematch.com/contact.

Source: mypeptidematch.com ↗
Side effects

Gastrointestinal side effects compound the problem

Nausea affects 44% of semaglutide users and 28% of tirzepatide users in clinical trials. Vomiting hits 24% and 13% respectively. Diarrhea affects 30% and 23%. These are not minor inconveniences. Each episode of vomiting or diarrhea strips nutrients from your body before they can be absorbed. When you are already eating less, losing nutrients through GI side effects creates a double hit. Your intake is down and your losses are up. This is why the first few months of GLP-1 therapy, when side effects are most common and dose titration is happening, represent the highest risk period for developing deficiencies. Constipation, which affects roughly one in four users, presents its own challenges. While it does not directly cause nutrient loss, it often leads people to reduce fiber intake further, which compounds the problem of inadequate nutrition.

Source: seekpeptides.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →